1 / 2

Neurodegenerative Diseases

Neurodegenerative Diseases. SIGMA-ALDRICH. Neurodegenerative Diseases

byron
Download Presentation

Neurodegenerative Diseases

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Neurodegenerative Diseases SIGMA-ALDRICH

  2. Neurodegenerative Diseases Neurodegenerative diseases are a varied assortment of central nervous system disorders characterized by neuronal loss and intraneuronal accumulations of fibrillary materials. Abnormal protein-protein interactions may allow the precipitation of these proteins, forming intracellular and extracellular aggregates. These abnormal interactions may play a role in the dysfunction and death of neurons in several common neurodegenerative diseases, such as Alzheimers Disease (AD) and Parkinsons Disease (PD). AD is characterized by loss of function and death of nerve cells in the brain leading to loss of cognitive function. The cause of nerve cell death is unknown but fibrillar b-amyloid senile plaques (SP) and intraneuronal tau-rich neurofibrillary tangles (NFT) are seen. SP form by the extracellular accumulation of amyloid beta (Ab) peptide into amyloid deposits, with the Ab 42 form being most predominant. Proteolytic enzymesb -secretase and g-secretase sequentially cleave the b-amyloid precursor protein (APP) into Ab. The enzyme BACE (b-site APP Cleaving Enzyme) has been identified as b-secretase. NFT are made up of aggregated hyperphosphorylated tau protein. Abnormal phosphorylation, possibly caused by mutations in the tau gene, may be one of the events leading to aggregation. Common polymorphisms of the apolipoprotein E (ApoE) gene and risk/age of onset of AD may be linked. The ApoE4 gene seems to carry more risk for an earlier onset of AD; the ApoE2 gene appears to be somewhat protective. ApoE can bind to both SP and NFT. PD is a slowly progressing, degenerative disease characterized by resting tremor, expressionless face, rigidity and slowness in initiating and performing voluntary movements. Neuropathologically, PD is characterized by loss of dopaminergic cell bodies in the substantia nigra, resulting in a reduced supply of dopamine in the basal ganglia. Intracellular inclusions called Lewy bodies, consisting of a-synuclein protein, are also seen. Mutations of the a-synuclein gene may cause the dominantly inherited Lewy-Body Parkinsons disease. The cause of the more common form of PD (multifactorial) is unknown, although it may be associated with oxidative stress and derangements in mitochondrial complex I activity.

More Related